Xencor Inc insider trading
Every open-market purchase and sale by Xencor Inc's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Xencor Inc’s insiders pay?
From August 13, 2014 to April 13, 2026, 13 insiders reported 15 open-market purchases and 101 sales not made under a pre-set plan in Xencor Inc. Twelve months after each purchase was reported, the shares were +52.8% against the S&P 500 on average (median +65.0%), over 15 purchases with a full year of prices; 73% beat the index. After sales, the shares moved −19.5% against the index over 12 months (a negative figure means selling was the right call). That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on June 21, 2017 into $20,968 by November 2, 2026, +8.3% a year. It held shares 22% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $12,818 (+2.7% a year), and held throughout $35,915 (+14.7%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Stafford John S III | 10% owner | 7 | +51.8% (7) | 71% | 11 | −3.3% (11) | April 8, 2020 |
| Desjarlais John R | SR. VICE PRESIDENT & CSO | 0 | — | — | 17 | −29.3% (14) | March 9, 2026 |
| Dahiyat Bassil I | PRESIDENT & CEO | 0 | — | — | 16 | −33.7% (13) | March 9, 2026 |
| Ronin Capital, LLC | 10% owner | 8 | +53.7% (8) | 75% | 7 | −19.3% (7) | March 23, 2020 |
| Kuch John J | SR. VICE PRESIDENT & CFO | 0 | — | — | 13 | −21.7% (13) | March 12, 2024 |
| Eckert Celia | SVP, GENERAL COUNSEL | 0 | — | — | 11 | −37.5% (9) | March 9, 2026 |
| Baracchini Edgardo Jr | Chief Business Officer | 0 | — | — | 6 | +1.5% (6) | August 13, 2018 |
| Yang Allen | SR. VICE PRESIDENT & CMO | 0 | — | — | 6 | −34.4% (6) | March 13, 2023 |
| Carter Bruce L A | Director | 0 | — | — | 5 | +38.9% (5) | June 16, 2017 |
| Cornelissen Bart Jan | SR. VICE PRESIDENT & CFO | 0 | — | — | 3 | +3.3% (1) | April 13, 2026 |
| Valente Nancy | EVP, Chief Development Officer | 0 | — | — | 3 | −25.0% (3) | May 6, 2025 |
| Foster Paul A | Chief Medical Officer | 0 | — | — | 2 | −1.9% (2) | August 17, 2018 |
| Gustafson Kurt A | Director | 0 | — | — | 1 | −56.5% (1) | March 7, 2024 |
When several insiders traded Xencor Inc
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Xencor Inc in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 2 buying crowds with six months of prices, it averaged +19.0% against the index. After 10 selling crowds, −2.2%. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| March 31, 2026 | 4 selling | +12.6% | +89.0% | not yet |
| March 31, 2025 | 4 selling | −34.9% | −9.5% | −0.7% |
| March 28, 2024 | 5 selling | −18.8% | −18.4% | −64.8% |
| March 31, 2023 | 5 selling | −19.5% | −35.3% | −51.6% |
| March 31, 2022 | 5 selling | +23.4% | +17.6% | +13.8% |
| March 31, 2021 | 3 selling | −28.3% | −35.7% | −53.4% |
| May 31, 2019 | 2 buying | +14.4% | +12.5% | −14.5% |
| June 29, 2018 | 3 selling | −2.4% | +4.6% | +7.5% |
| August 31, 2017 | 2 buying | −7.2% | +25.5% | +73.8% |
| March 31, 2017 | 3 selling | −14.8% | −11.8% | +7.7% |
| August 31, 2016 | 5 selling | +19.1% | +12.8% | −13.8% |
| June 30, 2015 | 3 selling | −36.4% | −35.7% | −18.3% |